| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Quest Diagnostics Incorporated (DGX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. DGX is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 132.4K | $25.75M | -10,000 | |
| VP | 83.7K | $16.27M | - | |
| VP | 38.3K | $7.46M | - | |
| VP | 34.5K | $6.70M | - | |
| CFO | 33.4K | $6.49M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2024 | Deppe Michael J | SVP, Corp. Controller &CAO | Sale+OE | 18,755 | $154.05 | $2,889,122.88 | -6.6% | +5.3% | +13.7% | |
| Oct 28, 2024 | Kuppusamy Karthik | SVP, Clinical Solutions | Sell | 1,775 | $156.92 | $278,525.19 | -15.4% | +2.6% | +14.3% | |
| Aug 29, 2024 | Prevoznik Michael E52 | SVP &General Counsel | Sale+OE | 32,551 | $154.97 | $5,044,516.36 | -45.8% | +4.5% | +16.3% | |
| Aug 28, 2024 | Kuppusamy Karthik | SVP, Clinical Solutions | Sell | 1,990 | $153.26 | $304,989.79 | -14.8% | +4.8% | +15.7% | |
| Jul 24, 2024 | Delaney Mark E | SVP &Chief Commercial Officer | Sell | 420 | $143.08 | $60,093.60 | -7.7% | +9.4% | +19.4% | |
| Apr 29, 2024 | Kuppusamy Karthik | SVP, Clinical Solutions | Sell | 1,760 | $140.00 | $246,400.00 | -11.6% | +1.9% | +28.0% | |
| Feb 29, 2024 | Prevoznik Michael E52 | SVP &General Counsel | Sell | 5,611 | $125.88 | $706,312.68 | -12.7% | +10.6% | +38.4% | |
| Feb 29, 2024 | Doherty Catherine T.55 | EVP, Regional Businesses | Sell | 6,744 | $126.45 | $852,769.05 | -4.7% | +10.6% | +38.4% | |
| Feb 23, 2024 | Gregg Vicky B | Director | Sell | 2,500 | $126.64 | $316,596.50 | -13.3% | +10.2% | +35.5% | |
| Feb 22, 2024 | Doherty Catherine T.55 | EVP, Regional Businesses | Sell | 821 | $126.14 | $103,560.94 | -1.1% | +13.2% | +37.4% |